Glycosaminoglycan-Replenishment Therapy: Rationale For Use and Current Evidence

Chairpeople:

Mauro Cervigni,¹ Phillip E. Van Kerrebroeck²

Speakers:

Paulo Dinis Oliveira,³ Rosanna Tarricone,⁴ Salvador Arlandis Guzman⁵

1. Polyclinic Gemelli, Catholic University, Rome, Italy
2. MUMC, Maastricht, the Netherlands
3. Hospital São João, Faculty of Medicine of Porto, Porto, Portugal
4. CERGAS Bocconi University, Milan, Italy
5. Hospital Universitario y Politécnico La Fe, Valencia, Spain

Disclosure:

The authors are invited speakers for IBSA Institut Biochimique SA and declare no conflicts of interest.

Acknowledgements:

Writing assistance provided by Dr Tabasum Mughal.

Support:

The publication of this article was funded by IBSA Institut Biochimique SA. The views and opinions expressed are those of the authors and not necessarily of IBSA Institut Biochimique SA.

Citation:

EMJ Urol. 2014;1[1]:41-47. DOI/10.33590/emjurol/10311640. https://doi.org/10.33590/emjurol/10311640.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.